Prostate Cancer: Diagnosis | Health News
Links shared publicly online about this topic.
- 1,012total visits
Prostate Cancer: Diagnosis | Health News
View full resource at healthnew.org
Tags: Rectum, Cancer, Prostate Cancer, Prostate, Men's Health
Most Recently Shared on July 18, 2010 at 9:09 pm By:
Prostate Cancer: Diagnosis | Health News http://bit.ly/cMXRIe
Urology News - Prebiopsy magnetic resonance spectroscopy and imaging in the diagnosis of prostate cancer |3990134
mdlinx.com — “Urology Medical Article: Prebiopsy magnetic resonance spectroscopy and imaging in the diagnosis of prostate cancer” View full resource at mdlinx.com
Most Recently Shared on March 29, 2012 at 12:14 pm By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Prebiopsy magnetic resonance spectroscopy and imaging in the diagnosis of prostate cancer: Internationa... http://t.co/2DUpL3oI #urology
Prostate Cancer Therapy Too Good to Be True Explodes Health Cost - Bloomberg
bloomberg.com — “Imagine a prostate cancer therapy that has almost no side effects. Hospitals say it exists and they’re vying to be among the first to offer it. Too bad the treatment may not work as well as advertised and could boost America’s already spiraling health-care costs.” View full resource at bloomberg.com
Most Recently Shared on March 26, 2012 at 12:27 pm By:
The ASCO Post Oncology, Health Magazine, and Hematology
#ProstateCancer Therapy Too Good to Be True Explodes #HealthCareCosts http://t.co/SQbc6mbO (via Bloomberg) #protons #radiotherapy
Women's Health Matters - Overweight or obese women may have lower breast cancer survival rates
womenshealthmatters.ca — “Canada’s leading women’s health information website. The latest information, news, resources and research from Women\'s College Hospital experts.” View full resource at womenshealthmatters.ca
Most Recently Shared on March 23, 2012 at 6:36 pm By:
Women'sHealthMatters Health Site
Study finds link between BMI at diagnosis and breast cancer outcomes http://t.co/5QJjdEG6
ingentaconnect Is using PHI for prostate cancer diagnosis in Europe worth it?
ingentaconnect.com — “ingentaconnect Is using PHI for prostate cancer diagnosis in Europe worth it?” View full resource at ingentaconnect.com
Most Recently Shared on March 22, 2012 at 5:44 am By:
Is using PHI for prostate cancer diagnosis in Europe worth it?: (Source: PharmacoEconomics and Outcomes News) http://t.co/fkUOfhEA
Prostate cancer expert disappointed by drug warning | CTV News
ctv.ca — “A noted prostate cancer researcher is not pleased with a warning issued this week by Health Canada about two popular medications used to treat enlarged prostates.” View full resource at ctv.ca
Most Recently Shared on March 20, 2012 at 4:24 pm By:
Prostate cancer expert disappointed by drug warning: A noted prostate cancer researcher is not pleased with a wa... http://t.co/bv2rTGyD
Lycopene Helps Prevent Prostate Cancer | Health and Wellness News
wellnessresources.com — “Lycopene is an antioxidant carotene that is responsible for the red color of tomatoes, one of the primary food sources in people's diets. Unlike beta carotene, lycopene does not potentially convert to vitamin A. Various studies have indicated that lycopene is associated with less occurrences of prostate cancer. Several new studies pinpoint precise mechanisms that explain why lycopene is a helpful nutrient for men who wish to reduce their risk for prostate cancer.” View full resource at wellnessresources.com
Most Recently Shared on March 19, 2012 at 4:37 pm By:
Wellness Resources Health Business
Lycopene is shown to reduce prostate cancer risk, in conjunction with other protective nutrients and a healthy... http://t.co/lCNjNVgH
MabCure Announces Agreement with the City University of New York Center for Advanced Technology to Validate and Evaluate Its Monoclonal Antibodies as Ovarian Cancer Diagnostic Reagents | BioPortfolio.com
bioportfolio.com — “From BioPortfolio: MabCure Inc., (OTCBB:MBCI) a leading developer of antibody based technology for the diagnosis and treatment of Ovarian, Prostate, Colorectal and other cancers t...” View full resource at bioportfolio.com
Most Recently Shared on March 19, 2012 at 2:05 pm By:
BioPortfolio News MabCure Announces Agreement with the City University of New York Center for ... http://t.co/OqO7kOiK BioPortfolio News
WEBLOG DO FRAGA
weblogdofraga.blogspot.com — “Daily News in Health and Aging” View full resource at weblogdofraga.blogspot.com
Most Recently Shared on March 18, 2012 at 3:03 am By:
john clay mchugh Urologist, Physician, Doctor, and Surgeon
Study finds PSA testing cuts prostate cancer... (WEBLOG DO FRAGA): Study finds PSA testing cuts prostate cancer ... http://t.co/8QuCUW6i
MedWire News - Prostate Cancer - Disparities in prostate cancer care exist by healthcare provider
medwire-news.md — “MedWire News Patients diagnosed with prostate cancer at private hospitals in the UK have an earlier disease stage at diagnosis, are more likely to be treated with surgery, and less likely to receive radiotherapy than those diagnosed at National Health Service hospitals, study findings indicate. MedWire News” View full resource at medwire-news.md
Most Recently Shared on March 17, 2012 at 6:34 am By:
Disparities in prostate cancer care exist by healthcare provider: Patients diagnosed with prostate cancer at pri... http://t.co/vvyVnC07
Oncology News - Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy |3980905
mdlinx.com — “Oncology Medical Article: Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy” View full resource at mdlinx.com
Most Recently Shared on March 16, 2012 at 8:24 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer ... http://t.co/NlNWZELq #oncology
MedWire News - Prostate Cancer - Disparities in prostate cancer care exist by healthcare provider
medwire-news.md — “MedWire News Patients diagnosed with prostate cancer at private hospitals in the UK have an earlier disease stage at diagnosis, are more likely to be treated with surgery, and less likely to receive radiotherapy than those diagnosed at National Health Service hospitals, study findings indicate. MedWire News” View full resource at medwire-news.md
Most Recently Shared on March 15, 2012 at 11:55 pm By:
john clay mchugh Urologist, Physician, Doctor, and Surgeon
Disparities in prostate cancer care exist by healthcare provider: Patients diagnosed with prostate cancer at pri... http://t.co/iDfGaSs0
Prostate cancer screening study adds to debate over PSA tests - HealthPop - CBS News
cbsnews.com — “New England Journal of Medicine study showed screening reduced odds of dying from prostate cancer 30 percent - but overall odds of dying remained the same Read more by Ryan Jaslow on CBS News' HealthPop.” View full resource at cbsnews.com
Most Recently Shared on March 15, 2012 at 4:39 pm By:
john clay mchugh Urologist, Physician, Doctor, and Surgeon
Prostate cancer screening study adds to debate over PSA tests: New England Journal of Medicine study showed scre... http://t.co/Q0qPqbFo
Public Health News Roundup: March 13 | Public Health
blog.rwjf.org — “NewPublicHealth” View full resource at blog.rwjf.org
Most Recently Shared on March 15, 2012 at 3:25 pm By:
RWJF Human Capital Health Organization
RT @rwjf_pubhealth: Circumcision May Help Protect Against #Prostate #Cancer: http://t.co/o6Gs818W
Breast cancer screenings failing NZ women - Health - NZ Herald News
nzherald.co.nz — “Serious problems in part of New Zealand's national breast cancer screening programme have led to delays in the diagnosis of the deadly disease in a number of women.” View full resource at nzherald.co.nz
Most Recently Shared on March 15, 2012 at 12:43 pm By:
George Huba, Ph.D. Doctor, Psychologist, and PhD
Breast cancer screenings failing NZ women - Serious problems in part of New Zealand's national breast cancer screeni... http://t.co/3w1WslHO
MDxHealth fourth quarter total revenues increase 48% to €0.9M
news-medical.net — “MDxHealth SA, a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today announced results for Q4 and full year 2011.” View full resource at news-medical.net
Most Recently Shared on March 15, 2012 at 12:06 pm By:
Prostate Cancer: MDxHealth fourth quarter total revenues increase 48% to €0.9M: MDxHealth SA, a leading molecula... http://t.co/V5r27Hld
Advertisement
